MPO and Stroke: We observed that the administration of ABAH, a specific irreversible MPO inhibitor, mitigated the inflammatory response, reduced MPO activity, and improved neurobehavioral scores, contributing to a significant improvement in survival rates by day 3 after stroke in the aged group.